Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
23,207,173
-
Share change
-
-1,509,396
-
Total reported value
-
$2,310,118,632
-
Put/Call ratio
-
640%
-
Price per share
-
$99.54
-
Number of holders
-
261
-
Value change
-
-$159,332,310
-
Number of buys
-
88
-
Number of sells
-
172
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2019
As of 30 Sep 2019,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
261 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,207,173 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, Conestoga Capital Advisors, LLC, MACQUARIE GROUP LTD, and Stephens Investment Management Group LLC.
This page lists
262
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.